. Author manuscript; available in PMC: 2013 May 22.

Published in final edited form as: Breast Cancer Res Treat. 2010 Aug 6;123(3):819–828. doi: 10.1007/s10549-010-1088-4

Table 2.

Mood and anxiety self-rating raw scores (mean (SD), number above threshold^*)

Time-point	Measure	CTx+ (N = 17)	CTx– (N = 12)	Control (N = 18)
Baseline	CES-D	8.2 (8.2), 2	5.7 (6.6), 1	4.5 (4.5), 0
	STAI-S	30.2 (10.4), 2	28.8 (13.1), 1	27.1 (7.2), 0
M1	CES-D	9.9 (10.3), 3	6.1 (5.7), 1	4.4 (4.6), 0
	STAI-S	30.8 (13.7), 2	27.1 (9.2), 1	27.3 (8.2), 1
Y1	CES-D	6.8 (6.2), 3	7.5 (10.4), 1	4.7 (8.9), 1
	STAI-S	27.6 (8.8), 1	28.3 (11.3), 1	25.6 (7.2), 0

There were no significant between-group differences at any time-point or any group-by-time interactions (P > .05)

CES-D Center for Epidemiologic Studies-Depression Scale, STAI-S State-Trait Anxiety Inventory-State Scale

Thresholds for significant symptomatology: CES-D raw score ≥16, STAI-S T score ≥65